EIF3F and neoplasm: Combination Treatment of NCT503 and LGK‐974 Mitigated Tumor Growth in eIF3f High Human PDX CRC Models with Better Efficacy through Hindering Wnt‐eIF3f‐PHGDH Signaling Axis